Johannes Gutenberg-Universität Mainz
- 6131/39-0
Kudo, Masatoshi; Finn, Richard S.; Morimoto, Manabu et al.
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)LIVER CANCER. Bd. 10. H. 5. 2021 S. 451-460
Kudo, Masatoshi; Ikeda, Masafumi; Galle, Peter R. et al.
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Outcomes by treatment-emergent ascitesHEPATOLOGY RESEARCH. Bd. 51. H. 6. 2021 S. 715-721
Galle, Peter R.; Kudo, Masatoshi; Llovet, Josep M. et al.
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiologyLIVER INTERNATIONAL. Bd. 41. H. 11. 2021 S. 2759-2767
Olschewski, Maximilian; Ullrich, Helen; Knorr, Maike et al.
Randomized non-inferiority TrIal comParing reverse T And Protrusion versus double-kissing and crush Stenting for the treatment of complex left main bifurcation lesionsCLINICAL RESEARCH IN CARDIOLOGY. Bd. 111. H. 7. 2021 S. 750-760
Harter, P.; Sehouli, J.; Vergote, I et al.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian CancerNEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 23. 2021 S. 2123-2131
Peter, Manuel; Aschauer, Dominik F.; Rose, Renata et al.
Rapid nucleus-scale reorganization of chromatin in neurons enables transcriptional adaptation for memory consolidationPLOS ONE. Bd. 16. H. 5. 2021
Dietz, Julia; Graf, Christiana; Muellhaupt, Beat et al.
RARE HCV GENOTYPES: PREVALENCE AND RESISTANCE-ASSOCIATED SUBSTITUTIONS IN DAA-NAIVE AND DAA-EXPERIENCED PATIENTSHEPATOLOGY. Bd. 74. 2021 S. 599A-600A
Hippert, Felicitas; Desing, Lena; Diez, Sonja et al.
Rare Tumors in Children and Adolescents - the STEP Working Group & apos;s Evolution to a Prospective RegistryKLINISCHE PADIATRIE. Bd. 234. H. 03. 2021 S. 146-153
Grosche, Sarah; Marenholz, Ingo; Esparza-Gordillo, Jorge et al.
Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4NATURE COMMUNICATIONS. Bd. 12. H. 1. 2021
Heilig, C. E.; Horak, P.; Kreutzfeldt, S. et al.
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trialESMO OPEN. Bd. 6. H. 6. 2021